BofA/Merrill Lynch Downgrades Emerson (EMR) to Neutral
Tweet Send to a FriendGet Alerts EMR Hot Sheet
Price: $57.89 -1.51%
Rating Summary:
4 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
4 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade EMR Now!
BofA/Merrill Lynch downgraded Emerson (NYSE: EMR) from Buy to Neutral.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $44.01 yesterday, with a 52 week range of $39.50-$64.56.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $44.01 yesterday, with a 52 week range of $39.50-$64.56.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
- Benchmark Boosts PT on R.R. Donnelley (RRD)
- Goldman Sachs Downgrades InterXion Holding (INXN) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
